Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Crypto stocks surge as Bitcoin short squeeze hits record $2.7B
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Co-Diagnostics (CODX) Tops Q2 EPS by 43c
August 14, 2025 4:02 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.23), $0.43 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More